1952
DOI: 10.3181/00379727-79-19419
|View full text |Cite
|
Sign up to set email alerts
|

Reduced Antibody Titers in Mice Treated with Carcinogenic and Cancer Chemotherapeutic Agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
18
0

Year Published

1960
1960
2011
2011

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 110 publications
(20 citation statements)
references
References 0 publications
1
18
0
Order By: Relevance
“…In contrast, in the present studies, Col did not depress immune responsiveness when injected up to 24 h before assessment of the PFC response ( Figs. 1 and 2), and it has been reported to be immunodepressive in vivo only when injected repeatedly (59,60) or at nearly toxic doses (61,62). In the present work as in previous reports (46,47), Col possessed adjuvant properties at concentrations approaching toxicity, and at concentrations that were toxic for individual animals, the surviving animals exhibited heightened immune responses.…”
Section: Inability Of Col Tosupporting
confidence: 66%
“…In contrast, in the present studies, Col did not depress immune responsiveness when injected up to 24 h before assessment of the PFC response ( Figs. 1 and 2), and it has been reported to be immunodepressive in vivo only when injected repeatedly (59,60) or at nearly toxic doses (61,62). In the present work as in previous reports (46,47), Col possessed adjuvant properties at concentrations approaching toxicity, and at concentrations that were toxic for individual animals, the surviving animals exhibited heightened immune responses.…”
Section: Inability Of Col Tosupporting
confidence: 66%
“…The authors state that since immunological function is compromised during (Malmgren et al 1952). The immunosuppressive effects of dibenz [a,h]anthracene were studied in AHH-inducible mice (C57BL/6) and AHH-noninducible mice (DBA/2N) by intraperitoneal and oral administration (Lubet et al 1984).…”
Section: Health Effectsmentioning
confidence: 99%
“…A growing body of evidence now indicates that substances classifiable as antimetabolites, of which 6-MP may be considered a prototype, are active "anti-immune" agents (11)(12)(13)(14)(15). This activity of these agents may have importance in respect to a widely used tool in the screening of chemotherapeutic agents for the treatment of cancer, namely, the transplantable tumor (16).…”
Section: Discussionmentioning
confidence: 99%